Javascript must be enabled to continue!
Enantioselective, Organocatalytic Morita-Baylis-Hillman and Aza-Morita-Baylis-Hillman Reactions: Stereochemical Issues
View through CrossRef
Conscious of the importance that stereochemical issues may have on the design of efficient organocatalyts for both Morita-Baylis-Hillman and aza-Morita-Baylis-Hillman reaction we have analyzed them in this minireview. The so-called standard reactions involve “naked” enolates which therefore should lead to the syn adducts as the major products, irrespective of the E, Z stereochemistry of the enolate. Accordingly, provided the second step is rate determining step, the design of successful bifunctional or polyfunctional catalysts has to consider the geometrical requirements imposed by the transition structures of the second step of these reactions. On the other hand, MBH and aza-MBH reactions co-catalyzed by (S)-proline and a secondary or tertiary amine (co-catalyst) involve the aldol-type condensation of either a 3-amino-substituted enamine, dienamine, or both, depending on the cases. A Zimmerman-Traxler mechanism defines the stereochemical issues regarding these co-catalyzed condensations which parallel those of the well established (S)-proline catalyzed aldol-like reactions.
Title: Enantioselective, Organocatalytic Morita-Baylis-Hillman and Aza-Morita-Baylis-Hillman Reactions: Stereochemical Issues
Description:
Conscious of the importance that stereochemical issues may have on the design of efficient organocatalyts for both Morita-Baylis-Hillman and aza-Morita-Baylis-Hillman reaction we have analyzed them in this minireview.
The so-called standard reactions involve “naked” enolates which therefore should lead to the syn adducts as the major products, irrespective of the E, Z stereochemistry of the enolate.
Accordingly, provided the second step is rate determining step, the design of successful bifunctional or polyfunctional catalysts has to consider the geometrical requirements imposed by the transition structures of the second step of these reactions.
On the other hand, MBH and aza-MBH reactions co-catalyzed by (S)-proline and a secondary or tertiary amine (co-catalyst) involve the aldol-type condensation of either a 3-amino-substituted enamine, dienamine, or both, depending on the cases.
A Zimmerman-Traxler mechanism defines the stereochemical issues regarding these co-catalyzed condensations which parallel those of the well established (S)-proline catalyzed aldol-like reactions.
Related Results
Baylis‐Hillman Reaction
Baylis‐Hillman Reaction
AbstractThe Baylis‐Hillman reaction is a three‐component reaction involving the coupling of the α‐position of activated alkenes with carbon electrophiles (i.e., aldehydes) under th...
Abstract 2842: 5-aza-2’-Deoxycytidine induces cellular senescence in non-small cell lung cancer
Abstract 2842: 5-aza-2’-Deoxycytidine induces cellular senescence in non-small cell lung cancer
Abstract
Background: Lung cancer is one of the refractory malignancies and the leading cause of cancer-related death worldwide. Although prognosis of lung cancer was...
Response To Azacitidine Is Independent Of TP53 Mutations In Higher-Risk Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)
Response To Azacitidine Is Independent Of TP53 Mutations In Higher-Risk Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)
Abstract
Introduction
Higher-risk myelodysplastic syndromes (MDS) progress to secondary acute myeloid leukemia (sAML) within mon...
Catalytic Systems for the Morita–Baylis–Hillman Reaction
Catalytic Systems for the Morita–Baylis–Hillman Reaction
A remarkable number of effective catalysts have been identified and developed for Morita-Baylis-Hillman reaction and its asymmetric version. This Chapter will discuss achiral or ch...
Morita–Baylis–Hillman Reaction
Morita–Baylis–Hillman Reaction
This Chapter will describe the origin and growth of Morita-Baylis-Hillman reaction, the reactant classes and reaction conditions, and also discuss the general catalytic mechanisms....
P412 Maintenance therapy of vedolizumab (VDZ) after induction of remission by tacrolimus (TAC) in patients with refractory ulcerative colitis (UC)
P412 Maintenance therapy of vedolizumab (VDZ) after induction of remission by tacrolimus (TAC) in patients with refractory ulcerative colitis (UC)
Abstract
Background
The number of patients with ulcerative colitis (UC) is increasing. As the number of patients increases, pati...
Synthetic drives for useful drug molecules through organocatalytic methods
Synthetic drives for useful drug molecules through organocatalytic methods
Abstract
The treatment of various pathological conditions in human beings involves the use of safe and efficacious drug substances. But there are different complicat...
Shoma Morita, Founder of Morita Therapy, and Haiku Poet Shiki: Origin of Morita Therapy
Shoma Morita, Founder of Morita Therapy, and Haiku Poet Shiki: Origin of Morita Therapy
Abstract: A hypothesis that Shiki's struggle for life probably influenced the creation of Morita therapy is presented. Although Morita had no personal acquaintance with Shiki, the...

